Previous studies indicate that reduced activity of regulatory T cells, such as IL-10-producing Tr1 cells or Foxp3+ Treg cells is associated with allergic disease (41, 42) and that allergen-specific immunotherapy might increase their activity (43). Here, FOXP3 is linked to allergic disease.